Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Applied Materials: Navigating Geopolitical Tensions in the AI Chip Race

Robert Sasse by Robert Sasse
November 24, 2025
in AI & Quantum Computing, Analysis, Semiconductors, Tech & Software
0
Applied Materials Stock
0
SHARES
82
VIEWS
Share on FacebookShare on Twitter

The semiconductor equipment giant Applied Materials finds itself at the heart of an escalating geopolitical struggle. As U.S. lawmakers prepare additional restrictions on technology transfers to China, the company strives to maintain its growth trajectory in the artificial intelligence era. Can Applied Materials preserve its leadership position despite regulatory challenges and recent earnings disappointments?

Record Annual Revenue Masks Quarterly Weakness

Applied Materials reported record full-year revenue for fiscal 2025, reaching $28.37 billion—a 4% increase over the previous year. However, this headline figure conceals emerging weaknesses. Fourth-quarter sales declined by 3%, while annual profits contracted by 2%.

The company did surpass analyst expectations for adjusted earnings per share, which came in at $2.17. This provided some consolation following August’s disappointing guidance that triggered a 14% stock plunge. Current projections for the first quarter of 2026 suggest continued challenges, with both revenue and earnings per share expected to fall significantly below prior-year levels.

Intensifying Regulatory Pressures

Washington is preparing fresh legislation that would prohibit recipients of CHIPS Act funding from sourcing specific semiconductor equipment from China. This represents the latest escalation in the technology conflict between the U.S. and China, potentially reshaping global supply chains in semiconductor manufacturing equipment.

While Applied Materials has stated it doesn’t anticipate further restrictions and claims to have largely absorbed the impact of previous export controls, the new legislative initiative raises critical questions. Future revenue streams from China could face disruption, and strategic partnerships may be jeopardized by these evolving trade policies.

Should investors sell immediately? Or is it worth buying Applied Materials?

Valuation Concerns Amid Competitive Landscape

Despite delivering a respectable 40% total return in 2025, Applied Materials has significantly underperformed its key competitors. Lam Research surged 107%, KLA gained 83%, and ASML advanced 54% during the same period, highlighting a substantial performance gap.

The company’s forward P/E ratio of approximately 24 sits 27% above its three-year average, which some analysts view as a cautionary signal. With a P/E multiple of 27, Applied Materials trades at a premium to the S&P 500’s average of 22.7. Market opinions remain divided, with 19 analysts recommending purchase and 15 maintaining hold ratings. The average price target currently stands at $226.74.

AI-Driven Growth Opportunities

The artificial intelligence revolution continues to drive substantial demand for advanced semiconductors and wafer fabrication equipment. Applied Materials is focusing on three core growth pillars: leading-edge logic chips, next-generation DRAM memory, and advanced packaging technologies.

Company leadership anticipates sluggish growth during the first half of 2026 but expects momentum to accelerate in the second half. The critical question facing investors is whether Applied Materials can leverage the AI technology transition to sustain its growth narrative despite geopolitical headwinds and valuation concerns.

Ad

Applied Materials Stock: Buy or Sell?! New Applied Materials Analysis from March 25 delivers the answer:

The latest Applied Materials figures speak for themselves: Urgent action needed for Applied Materials investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Applied Materials: Buy or sell? Read more here...

Tags: Applied Materials
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Voestalpine Stock

Voestalpine Shares Surge as Major Bank Issues Bullish Upgrade

Metaplanet Stock

Metaplanet Investors Face Market Reckoning as Bitcoin Plummets

Bionxt Solutions Stock

BioNxt Solutions Secures Key Patent, Unlocks Major Market Potential

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com